Search "tirzepatide-5-mg" (35 Offers)
British Dragon Pharmaceuticals
Product Information
British DragonCompound Details
Active Substance Letrozole Oral aromatase inhibitor
2.5 mg per tablet
Form Oral Tablets
Packaging 50 or 100 Tablets
Estimated Half-Life Approximately 2 Days
Detection Up to several weeks
Primary Mechanism Aromatase Inhibition
Estrogen Suppression Very High
British Dragon Pharmaceuticals
Product Information
British DragonCompound Details
Active Substance Ipamorelin Lyophilized growth hormone releasing peptide
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Approximately 2 Hours
Detection Up to several weeks
Primary Mechanism Ghrelin / GHS-R1a Receptor Agonism
GH / IGF-1 Impact Moderate to High
British Dragon Pharmaceuticals
Product Information
British DragonCompound Details
Active Substance Sermorelin Acetate Lyophilized GHRH analogue (GHRH 1-29)
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Approximately 10–20 Minutes
Detection Up to several weeks
Primary Mechanism GHRH Receptor Agonism
GH / IGF-1 Impact Moderate
British Dragon Pharmaceuticals
Product Information
British DragonCompound Details
Active Substance Tesamorelin Lyophilized GHRH analogue (GHRH 1-44)
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Approximately 30–40 Minutes
Detection Up to several weeks
Primary Mechanism GHRH Receptor Agonism
GH / IGF-1 Impact Moderate to High
Kalpa Pharmaceuticals LTD, India
Product Information
Kalpa PharmaceuticalsCompound Details
Active Substance Ipamorelin Lyophilized growth hormone releasing peptide
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Approximately 2 Hours
Detection Up to several weeks
Primary Mechanism Ghrelin / GHS-R1a Receptor Agonism
GH / IGF-1 Impact Moderate to High
Kalpa Pharmaceuticals LTD, India
Product Information
Kalpa PharmaceuticalsCompound Details
Active Substance Sermorelin Acetate Lyophilized GHRH analogue (GHRH 1-29)
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Approximately 10–20 Minutes
Detection Up to several weeks
Primary Mechanism GHRH Receptor Agonism
GH / IGF-1 Impact Moderate
Kalpa Pharmaceuticals LTD, India
Product Information
Kalpa PharmaceuticalsCompound Details
Active Substance Tesamorelin Lyophilized GHRH analogue (GHRH 1-44)
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Approximately 30–40 Minutes
Detection Up to several weeks
Primary Mechanism GHRH Receptor Agonism
GH / IGF-1 Impact Moderate to High
Peptide Hubs
Product Information
Peptide HubsCompound Details
Active Substance Tesamorelin Lyophilized GHRH analogue (GHRH 1-44)
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Approximately 30–40 Minutes
Detection Limited data · Up to several weeks
Primary Mechanism GHRH Receptor Agonism
GH / IGF-1 Impact Moderate to High
Axiolabs
Product Information
AxiolabsCompound Details
Active Substance Ipamorelin Lyophilized growth hormone releasing peptide
5 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Approximately 2 Hours
Detection Up to several weeks
Primary Mechanism Ghrelin / GHS-R1a Receptor Agonism
GH / IGF-1 Impact Moderate to High